Skip to main content

Baird Financial Group, Inc.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1648711 MILWAUKEE, WI

Position in NBIX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$6,719,350
+$1,635,636 QoQ
Shares Held
39,868
+3.3% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#182
of 768 holders
Holding Since
Mar 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Baird Financial Group, Inc. holds $29,735,464 across 12 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (22.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
39,868 $6,719,350

All Filings in NBIX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,719,350 39,868
2026-03-31 $5,083,714 38,589
2025-12-31 $5,985,934 42,205
2025-09-30 $6,592,382 46,961
2025-06-30 $6,711,090 53,394
2025-03-31 $6,394,890 57,820
2024-12-31 $7,468,869 54,717
2024-09-30 $3,463,513 30,060
2024-06-30 $9,494,547 68,966
2024-03-31 $4,436,472 32,167
2023-12-31 $3,371,078 25,585
2023-09-30 $2,972,474 26,422
2023-06-30 $2,474,807 26,244
2023-03-31 $1,268,690 12,534
2022-12-31 $2,083,513 17,472
2021-12-31 $294,688 3,460
2021-09-30 $331,848 3,460
2021-06-30 $336,727 3,460
2021-03-31 $434,999 4,473